Cancer Information Highlights |
From the National Cancer Institute |
Updating you about cancer causes, prevention, screening, treatment, coping, and more |
|
|
Drug Information Updates |
Pembrolizumab and Lenvatinib Mesylate for Endometrial Cancer
We’ve updated our drug information summaries on pembrolizumab (Keytruda) and lenvatinib mesylate (Lenvima) with a recent FDA approval. These drugs are now approved to be used together to treat patients with advanced endometrial cancer that has specific genetic changes and that got worse after other treatments. |
|
|
Also of Interest |
Children with Cancer: A Guide for Parents
If your child has cancer, this booklet can help you every step of the way. Order one free copy, print the PDF, or download it to an e-reader. |
Using Trusted Resources
Health information, whether in print or online, should come from a credible source. Learn how to recognize information that is based on research from sources you can trust. |
|
|
|
|